About

China Grand Enterprises (CGE) operates as an investment company whose business covers pharmaceuticals, commercial trade, real estate and finance. The company is also a parent company of three publicly-traded companies: China Grand Pharmaceutical and Healthcare Holdings, Huadong Medicine and Grand Industrial Holding. The CGE legal team has been working on domestic and international M&A, contract management, IP, compliance and disputes resolution. Alongside its day-to-day work, the legal team also focuses on building effective and efficient mechanisms to help to grow CGE’s business. For instance, it has built a system of contract management including – but not limited – to contract planning, template making, contract monitoring and risk submission, which help to make a virtuous circle in day-to-day risk control and business operation. They also summarise practical SOPs in terms of due diligence, legal documents, closing checklist and working standard for M&AS. The legal team also thinks IP will be a profit-creating point for the business and push forward CGE group’s IP strategies and layouts. The legal team is commended by nominators for being fully prepared to deal with these matters in advance: ‘All [of the] legal team’s work is arranged in advance, and in particular, the work relating to IP is planned ahead of schedule’, says a nominator. CGE’s IP work forms a complete patent-related work chain in which the layout is established in advance, application as planned and IP exploitation and market surveillance is effectively analysed. Shi Yingchun leads the department as legal president for over seven years and is credited with establishing the legal management model to cover the company’s main businesses as well as intellectual property management, business administration affairs and safe operation management.